Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes

Journal of Virological Methods

Volumn 66, Issue 2, 1997, Pages 293-301

  Gobbers, E ^a   Fransen, K ^b   Oosterlaken, T ^a   Janssens, W ^b   Heyndrickx, L ^b   Ivens, T ^b   Vereecken, K ^b   Schoones, R ^a   Van De Wiel, P ^a   Van Der Groen, G ^b  

^a Organon Teknika   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

HIV 1 RNA load; HIV 1 subtypes; NASBA; RT PCR

Indexed keywords

ANIMAL CELL; ARTICLE; BIODIVERSITY; CELL CULTURE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 17044450315     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00072-4     Document Type: Article

References (28)

1. Braaten, D., Franke, E.K., Luban, J., 1996. Cyclophylin A is required for the replication of group M human immunodeficiency virus type 1 and simian immunodeficiency virus SIVcpzgab but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70, 4220-4227.
2. Christopherson, C.D., Kwok, S., 1996. The effects of mutations on HIV-1 quantitation by RT/PCR. XI Int Conf on AIDS, Vancouver 7-12 July 1996 (Abstract).
3. Compton, J., 1991. Nucleic acid sequence-based amplification. Nature 350, 91-92.
4. Coste, J., Montes, B., Reynes, J., Peeters, M., Segarra, C., Vendrell, J.P., Delaporte, E., Segondy, M., 1996. Comparative evaluation of three assays for the quantitation of Human Immunodeficiency Virus Type 1 RNA in plasma. J. Med. Virol. 50, 293-302.
5. Delaporte, E., Janssens, W., Peeters, M., Buvé, A., Dibanga, G., Perret, J.L., Ditsambou, V., Mba, J.R., Courbot, M.C.G., Georges, A., Bourgeois, A., Samb, B., Henzel, D., Heyndrickx, L., Fransen, K., van der Groen, G., Larouze, B., 1996. Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS 10, 903-910.
6. Delwart, E.L., Shpaer, E.G., Louwagie, J., McCutchan, F.E., Grez, M., Rübsamen-Waigmann, H., Mullins, J.I., 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262, 1257-1261.
7. Garry, R.F., Fermin, C.D., 1993. Viral burden in AIDS. Nature 365, 301-302.
8. Heyndrickx, L., Alary, M., Janssens, W., Davo, N., van der Groen, G., 1996. HIV-1 group O and group M infection in Benin. Lancet 347, 902-903.
9. Janssens, W., Heyndrickx, L., Fransen, K., Motte, J., Peeters, M., Nkengasong, J., Ndumbe, P.M., Perret, J.L., Atende, C., Piot, P., van der Groen, G., 1994. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10, 577-579.
10. Janssens, W., et al., (in preparation).
11. Jurriaans, S., Weverling, G.J., Goudsmit, J., Boogaard, J., Brok, M., van Strijp, D., Lange, J., Koot, M., van Gemen, B., 1995. Distinct changes in HIV type 1 RNA versus p24 antigen in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS. AIDS Res. Hum. Retroviruses 10, 473-479.
12. Loussert-Ajaka, I., Descamps, D., Simon, F., Brun-Vézinet, F., Ekwalanga, M., Saragosti, S., 1995. Genetic diversity and HIV detection by polymerase chain reaction. Lancet 346, 912-913.
13. Louwagie, J., Janssens, W., Mascola, J., Heyndrickx, L., Hegerich, P., van der Groen, G., McCutchan, F.E., Burke, D.S., 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69, 263-271.
14. Louwagie, J., McCutchan, F.E., Peeters, M., Brennan, T.P., Sanders-Buell, E., Eddy, G.A., van der Groen, G., Fransen, K., Gershy-Damet, G.M., Deleys, R., Burke, D.S., 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7, 769-780.
15. McCutchan, F.E., Salminen, M.O., Carr, J.K., Burke, D.S., 1996. HIV-1 genetic diversity. AIDS 10 (suppl 3), S13-S20.
16. Nkengasong, J., Janssens, W., Heyndrickx, L., Fransen, K., Ndumbe, P., Motte, J., Leonaers, A., Ngolle, M., Ayuk, J., Piot, P., van der Groen, G., 1994a. Genotypic subtypes of HIV-1 in Cameroon. AIDS 8, 1405-1412.
17. Nkengasong, J., Peeters, M., Ndumbe, P., Janssens, W., Willems, B., Fransen, K., Ngolle, M., Piot, P., van der Groen, G., 1994b. Cross-neutralizing antibodies to HIV-1 ANT70 and HIV-1 IIIB in sera of African and Belgian HIV-1 infected individuals. AIDS 8, 1089-1096.
18. Nyambi, P.N., Nkengasong, J., Peeters, M., Simon, F., Eberle, J., Janssens, W., Fransen, K., Willems, B., Vereecken, K., Heyndrickx, L., Piot, P., van der Groen, G., 1995. Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J. Infect. Dis. 172, 1228-1237.
19. Robertson, D.L., Sharp, P.M., McCutchan, F.E., Hahn, B.H., 1995. Recombination in HIV-1. Nature 374, 124-126.
20. Saag, M.S., Holodniy, M., Kuritzkes, D.R., O'Brien, W.A., Coombs, R., Poscher, M.E., Jacobsen, D.M., Shaw, G.M., Richmann, D.D., Volberding, P.A., 1996. HIV viral load markers in clinical practice. Nat. Med. 2, 625-629.
21. Schuurman, R., Descamps, D., Weverling, G.J., Kaye, S., Tijnagel, J., Williams, I., van Leeuwen, R., Tedder, R., Boucher, C.A.B., Brun-Vézinet, F., Loveday, C., 1996. Multicenter comparison of three commercial methods for quantification of Human Immunodeficiency Virus Type 1 RNA in plasma. J. Clin. Microbiol. 34, 3016-3022.
22. Songok, E.M., Libondo, D.K., Rotich, M.C., Oogo, S.A., Tukei, P.M., 1996. Surveillance for HIV-1 subtypes O and M in Kenya. Lancet 347, 1700.
23. Todd, J., Pahl, C., White, S., Yeghiazarian, T., Johnson, P., Taylor, B., Holodniy, M., Kern, D., Hamren, S., Chernoff, D., Urdea, M., 1995. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. AIDS 10, S35-S44.
24. Vandamme, A.M., Schmit, J.C., van Dooren, S., van Laethem, K., Gobbers, E., Kok, W., Goubau, P., Peetermans, W., de Clercq, E., Desmyter, J., 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and with the AMPLICOR HIV MONITOR test. J. AIDS. 13, 127-139.
25. Vandamme, A.M., van Dooren, S., Kok, W., Goubau, P., Fransen, K., Kievits, T., Schmit, J.C., de Clercq, E., Desmyter, J., 1995. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J. Virol. Methods. 52, 121-132.
26. Vanden Haesevelde, M., Decourt, J.L., Deleys, R.J., Vanderborght, B., van der Groen, G., van Heuverswijn, H., Saman, E., 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68, 1586-1596.
27. Van Gemen, B., van Beuningen, R., Nabbe, A., van Strijp, D., Jurriaans, S., Lens, P., Kievits, T., 1994. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J. Virol. Methods 43, 177-188.
28. Zhong, P., Peeters, M., Janssens, W., Fransen, K., Heyndrickx, L., Vanham, G., Willems, B., Piot, P., van der Groen, G., 1995. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B and D. AIDS Res. Hum. Retroviruses 11, 239-248.